We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.83B
AUM Growth
+$508M
Cap. Flow
+$309M
Cap. Flow %
16.91%
Top 10 Hldgs %
53.61%
Holding
96
New
26
Increased
25
Reduced
14
Closed
27

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$52.8M
2
CELG
Celgene Corp
CELG
+$51.8M
3
BIIB icon
Biogen
BIIB
+$47.2M
4
PCRX icon
Pacira BioSciences
PCRX
+$41.8M
5
BURL icon
Burlington
BURL
+$32.2M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$73.6M
2
SGI
Somnigroup International
SGI
+$34.1M
3
SRCL
Stericycle Inc
SRCL
+$31.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$26.1M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$23.9M

Sector Composition

Rank Sector Weight
1 Healthcare 35.87%
2 Consumer Discretionary 11.8%
3 Consumer Staples 6.82%
4 Industrials 4.98%
5 Communication Services 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$452M 24.74%
1,600,000
+100,000
+7% +$27.2M
AVTX icon
2
Avalo Therapeutics
AVTX
$976M
$107M 5.85%
6,356
+61
+1% +$913K
CVS icon
3
CALL
CVS Health
CVS
$137B
$74.9M 4.1%
1,250,000
+1,050,000
+525% +$64.8M
ENR icon
4
Energizer
ENR
$1.44B
$58.2M 3.19%
1,296,000
+228,000
+21% +$10.5M
CELG
5
DELISTED
Celgene Corp
CELG
$55.8M 3.06%
+592,000
New +$51.8M
MDGL icon
6
Madrigal Pharmaceuticals
MDGL
$12.6B
$53.2M 2.91%
+425,000
New +$52.8M
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$52.1M 2.85%
2,100,000
-2,936,000
-58% -$73.6M
AMAG
8
DELISTED
AMAG Pharmaceuticals
AMAG
$42.7M 2.34%
3,316,000
+1,438,000
+77% +$21.4M
EPC icon
9
Edgewell Personal Care
EPC
$1.27B
$42.7M 2.34%
972,000
-48,000
-5% -$2M
PCRX icon
10
Pacira BioSciences
PCRX
$1.02B
$40.8M 2.23%
+1,072,000
New +$41.8M
FTDR icon
11
Frontdoor
FTDR
$5.02B
$39M 2.13%
1,132,000
+532,000
+89% +$16.2M
HAIN icon
12
CALL
Hain Celestial
HAIN
$47.8M
$37M 2.02%
+1,600,000
New +$30.8M
DFRG
13
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$35.9M 1.96%
5,600,000
+1,072,000
+24% +$8.45M
ENTA icon
14
Enanta Pharmaceuticals
ENTA
$372M
$35.5M 1.94%
372,000
-128,000
-26% -$11.5M
BIIB icon
15
Biogen
BIIB
$29.9B
$35.5M 1.94%
+150,000
New +$47.2M
WBT
16
DELISTED
Welbilt, Inc.
WBT
$32.8M 1.79%
2,000,000
+242,000
+14% +$3.53M
MNK
17
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$32.6M 1.78%
1,500,000
-800,000
-35% -$17.1M
TGT icon
18
Target
TGT
$62.1B
$32.1M 1.76%
400,000
+300,000
+300% +$21.9M
BURL icon
19
Burlington
BURL
$22B
$31.3M 1.72%
+200,000
New +$32.2M
ATRS
20
DELISTED
Antares Pharma, Inc.
ATRS
$31.2M 1.71%
10,300,000
– –
VYGR icon
21
Voyager Therapeutics
VYGR
$187M
$29.4M 1.61%
1,536,000
-1,300,000
-46% -$16.9M
AZO icon
22
AutoZone
AZO
$48.3B
$28.7M 1.57%
28,000
+12,000
+75% +$10.8M
PLYA
23
DELISTED
Playa Hotels & Resorts
PLYA
$27.3M 1.5%
3,580,000
-2,092,000
-37% -$16.2M
SJM icon
24
CALL
J.M. Smucker
SJM
$12.6B
$23.3M 1.28%
200,000
– –
CPB icon
25
CALL
Campbell Soup
CPB
$6.51B
$22.9M 1.25%
+600,000
New +$21.2M
1
2 3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Armistice Capital held 96 positions worth $1.83B, up 38% from $1.32B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $309M of net new capital in Q1 2019, opening 26 new positions and adding to 25 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 425,000 shares worth $53.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Clovis Oncology, Inc., an estimated $73.6M trimmed.

  • Armistice Capital's largest Q1 2019 buy was Madrigal Pharmaceuticals: 425,000 shares worth $53.2M.
  • Armistice Capital added most to Target in Q1 2019, an estimated $21.9M increase.
  • Armistice Capital's biggest Q1 2019 reduction was Clovis Oncology, Inc., cutting an estimated $73.6M.
  • Armistice Capital fully exited Somnigroup International in Q1 2019, selling an estimated $34.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $1.83B portfolio in Q1 2019.
  • Armistice Capital opened 26 new positions and closed 27 in Q1 2019.
  • Armistice Capital's portfolio value rose 38% quarter-over-quarter to $1.83B.

Based on Armistice Capital's 13F filing for Q1 2019, filed 15 May 2019.